Assembly Biosciences, Inc.
ASMB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $24 | $23 | $38 |
| Short-Term Investments | $210 | $51 | $68 | $74 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $2 | $4 | $3 |
| Total Curr. Assets | $237 | $77 | $96 | $116 |
| Property Plant & Equip (Net) | $3 | $3 | $3 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $3 | $3 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $240 | $81 | $99 | $119 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $1 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $41 | $38 |
| Other Curr. Liab. | $51 | $46 | $4 | $9 |
| Total Curr. Liab. | $53 | $47 | $47 | $48 |
| LT Debt | $2 | $2 | $2 | $3 |
| Deferred Rev, NC | $0 | $0 | $23 | $35 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $13 | $0 | $0 |
| Total NC Liab. | $4 | $15 | $25 | $38 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $3 | $3 | $3 |
| Total Liabilities | $57 | $63 | $72 | $86 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$854 | -$845 | -$835 | -$826 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $1,037 | $863 | $862 | $859 |
| Total Equity | $183 | $18 | $27 | $33 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $240 | $81 | $99 | $119 |
| Net Debt | -$20 | -$21 | -$20 | -$35 |